NOV antibody (AA 221-320) (Cy3)
Quick Overview for NOV antibody (AA 221-320) (Cy3) (ABIN761819)
Target
See all NOV AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 221-320
-
Cross-Reactivity
- Human, Mouse, Rat
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human IGFBP9/CCN3
-
Isotype
- IgG
-
-
-
-
Application Notes
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- NOV (Nephroblastoma Overexpressed (NOV))
-
Alternative Name
- IGFBP9
-
Background
-
Synonyms: CCN3, NOVh, IBP-9, IGFBP9, IGFBP-9, Protein NOV homolog, CCN family member 3, Insulin-like growth factor-binding protein 9, IGF-binding protein 9, Nephroblastoma-overexpressed gene protein homolog, NOV
Background: Immediate-early protein likely to play a role in cell growth regulation.
-
Gene ID
- 4856
-
UniProt
- P48745
-
Pathways
- Smooth Muscle Cell Migration, Growth Factor Binding
Target
-